Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2023 is -24.24% vs 50.00% in Jun 2023
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2023 is -86.49% vs 75.42% in Jun 2023
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2023 is 22.29% vs 29.60% in Jun 2023
Interest
QoQ Growth in quarter ended Sep 2023 is 23.33% vs 3.45% in Jun 2023
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2023 has fallen from Jun 2023
Compare Quarterly Results Of Impel Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2023 is -24.24% vs 50.00% in Jun 2023
YoY Growth in quarter ended Sep 2023 is 61.29% vs 3,000.00% in Sep 2022
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2023 is -86.49% vs 75.42% in Jun 2023
YoY Growth in quarter ended Sep 2023 is 55.63% vs -24.40% in Sep 2022
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2023 is 22.29% vs 29.60% in Jun 2023
YoY Growth in quarter ended Sep 2023 is 41.63% vs 5.43% in Sep 2022
Quarterly - Interest
QoQ Growth in quarter ended Sep 2023 is 23.33% vs 3.45% in Jun 2023
YoY Growth in quarter ended Sep 2023 is 15.62% vs 0.00% in Sep 2022
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2023 has fallen from Jun 2023
YoY Growth in quarter ended Sep 2023 has improved from Sep 2022






